Literature DB >> 28351938

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.

Lohith S Bachegowda1, Rima M Saliba1, Reshma Ramlal1, Piyanuch Kongtim1, Julianne Chen1, Gabriela Rondon1, Whitney Wallis1, Amin Alousi1, Sairah Ahmed1, Chitra M Hosing1, Simrit Parmar1, Muzaffar Qazilbash1, Issa F Khouri1, Qaiser Bashir1, Betul Oran1,2, Uday Popat1,2, Elizabeth J Shpall1,2, David Marin1,2, Katayoun Rezvani1,2, Partow Kebriaei1,2, Richard E Champlin1,2, Stefan O Ciurea1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28351938      PMCID： PMC6033074          DOI： 10.1182/blood-2017-02-766154

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Acute myeloid leukemia.

Authors:  B Löwenberg; J R Downing; A Burnett
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

2.  Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511-533.

Authors: 
Journal:  Blood       Date:  2016-11-17       Impact factor: 22.113

3.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

4.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

5.  A disease risk index for patients undergoing allogeneic stem cell transplantation.

Authors:  Philippe Armand; Christopher J Gibson; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Jerome Ritz; Mohamed L Sorror; Stephanie J Lee; H Joachim Deeg; Barry E Storer; Frederick R Appelbaum; Joseph H Antin; Robert J Soiffer; Haesook T Kim
Journal:  Blood       Date:  2012-06-18       Impact factor: 22.113

6.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Authors:  M L Slovak; K J Kopecky; P A Cassileth; D H Harrington; K S Theil; A Mohamed; E Paietta; C L Willman; D R Head; J M Rowe; S J Forman; F R Appelbaum
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

7.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

Authors:  E W Petersdorf; T A Gooley; C Anasetti; P J Martin; A G Smith; E M Mickelson; A E Woolfrey; J A Hansen
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

Review 8.  Hematopoietic stem cell transplantation for patients with AML in first complete remission.

Authors:  Jan J Cornelissen; Didier Blaise
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

9.  Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Victor Mulanovich; Rima M Saliba; Ulas D Bayraktar; Ying Jiang; Roland Bassett; Sa A Wang; Marina Konopleva; Marcelo Fernandez-Vina; Nivia Montes; Doyle Bosque; Julianne Chen; Gabriela Rondon; Gheath Alatrash; Amin Alousi; Qaiser Bashir; Martin Korbling; Muzaffar Qazilbash; Simrit Parmar; Elizabeth Shpall; Yago Nieto; Chitra Hosing; Partow Kebriaei; Issa Khouri; Uday Popat; Marcos de Lima; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-11       Impact factor: 5.742
  9 in total
  3 in total

1.  Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome.

Authors:  Piyanuch Kongtim; Simrit Parmar; Denái R Milton; Jorge Miguel Ramos Perez; Gabriela Rondon; Julianne Chen; Abhishek R Chilkulwar; Gheath Al-Atrash; Amin Alousi; Borje S Andersson; Jin S Im; Chitra M Hosing; Qaiser Bashir; Issa Khouri; Partow Kebriaei; Betul Oran; Uday Popat; Richard Champlin; Stefan O Ciurea
Journal:  Bone Marrow Transplant       Date:  2018-09-26       Impact factor: 5.483

2.  Thrombopoietin enhances hematopoietic stem and progenitor cell homing by impeding matrix metalloproteinase 9 expression.

Authors:  Yiming Liu; Li Ding; Bowen Zhang; Ziliang Deng; Yi Han; Sihan Wang; Shu Yang; Zeng Fan; Jing Zhang; Hongmin Yan; Dongmei Han; Lijuan He; Wen Yue; Hengxiang Wang; Yanhua Li; Xuetao Pei
Journal:  Stem Cells Transl Med       Date:  2020-03-03       Impact factor: 6.940

Review 3.  Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Catherine J Lee; Bipin N Savani; Mohamad Mohty; Myriam Labopin; Annalisa Ruggeri; Christoph Schmid; Frédéric Baron; Jordi Esteve; Norbert C Gorin; Sebastian Giebel; Fabio Ciceri; Arnon Nagler
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.